Literatur
-
1 Akerblom H J, Virtanen S M, Hämäläinen. et al .Modulation of the appearance of diabetes
associated autoantibodies in the nutritional prevention of type
1 diabetes (TRIGR) project. Abstract book 4th
immunology of Diabetes Society Congress 1999: 123
-
2
Atkinson M A, MacLaren N K.
The pathogenisis
of insulin-dependent diabetes mellitus.
New England Journal
of Medicine.
1994;
331
1428-1436
-
3
Bingley P J, Bonifacio E, Williams A J, Genovese S, Bottazzo G F, Gale E A.
Prediction of
IDDM in the general population: strategies based on combinations
of autoantibody markers.
Diabetes.
1997;
46
1701-1710
-
4
Bingley P J, Bonifacio E, Ziegler A G, Schatz D A, Atkinson M A, Eisenbarth G S. on behalf of
the Immunology of Diabetes Society .
Proposed Guidelines
on Screening for Risk of Type 1 Diabetes.
Diabetes Care.
2001;
24
398
-
5
Christie M R, Roll U, Payton M A, Hatfield E C, Ziegler A G.
Validity
of screening for individuals at risk for type I diabetes by combined
analysis of antibodies to recombinant proteins.
Diabetes
Care.
1997;
20
965-970
-
6
Dittler J, Seidel D, Schenker M, Ziegler A G.
GADIA2-combi
determination as first-line screening for improved prediction of
type 1 diabetes in relatives.
Diabetes.
1998;
47
592-597
-
7
Feeney S J, Myers M A, Mackay I R, Zimmet P Z, Howard N, Verge C F, Rowley M J.
Evaluation
of ICA512As in combination with other islet cell autoantibodies
at the onset of IDDM.
Diabetes Care.
1997;
20
1403-7
-
8
Füchtenbusch M, Ferber K, Standl E, Ziegler A G.
Prediction
of type 1 diabetes postpartum in patients with gestational diabetes
mellitus by combined islet cell autoantibody screening: a prospective
multicenter study.
Diabetes.
1997;
46
1459-1467
-
9
Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler A G.
Delay
of type I diabetes in high risk, first degree relatives by parenteral antigen
administration: The Schwabing Insulin Prophylaxis Pilot Trial.
Diabetologia.
1998;
41
536-541
-
10
Ido Y, Vindigni A, Chang K. et al .
Prevention
of vascular and neural dysfunction in diabetic rats by C-peptide.
Science.
1997;
277
563-566
-
11
Lohmann T, Seissler J, Verlohren H J, Schroder S, Rotger J, Dahn K, Morgenthaler N, Scherbaum W A.
Distinct
genetic and immunological features in patients with onset of IDDM
before and after age 40.
Diabetes Care.
1997;
20
524-529
-
12
Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R.
Prevention of autoimmune
diabetes in NOD mice by 1,25 dihydroxyvitamin D3.
Diabetologia.
1994;
37
552-558
-
13
Rewers M, Bugawan T L, Norris J M, Blair A, Beaty B, Hoffman M, McDuffie R S Jr, Hamman R F, Klingensmith G, Eisenbarth G S, Erlich H A.
Newborn screening
for HLA markers associated with IDDM: diabetes autoimmunity study
in the young (DAISY).
Diabetologia.
1996;
39
807-812
-
14
Roll U, Ziegler A G.
Combined
antibody screening for improved prediction of IDDM - Modern
strategies.
Exp Clin Endocrinol Diabetes.
1997;
105
1-14
-
15
Schatz D, Krischer J, Horne G, Riley W, Spillar R, Silverstein J, Winter W, Muir A, Drovanesian D, Shah S, Malone J, MacLaren N.
Islet
cell antibodies predict insulin-dependent diabetes in United States
school age children as powerfully as in unaffected relatives.
J
Clin Invest.
1994;
93
2403-2407
-
16
Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert E D, Janka H U, Kastendiek C, Sorger M, Louwen F, Ziegler A G.
Early
expression and high prevalence of islet autoantibodies for DR3/4
heterozygous and DR4/4 homozygous offspring of parents
with Type I diabetes: The German BABYDIAB study.
Diabetologia.
1999;
42
671-677
-
17
Schloot N C, Pozzilli P, Mandrup-Poulsen T.
Immune
markers for monitoring the progression of autoimmune disease.
Diabetes
Metab Res Rev.
1999;
15
141-145
-
18
Seissler J, Hering B, Richter W, Gluck M, Yassin N, Bretzel R G, Boehm B O, Federlin K, Scherbaum W A.
Antibodies
to the M(r) 64,000 (64K) protein in islet cell antibody positive
non-diabetic individuals indicate high risk for impaired beta-cell
function.
Diabetologia.
1992;
35
550-554
-
19
Strebelow M, Schlosser M, Ziegler B, Rjasanowski I, Ziegler M.
Karlsburg Type
I diabetes risk study of a general population: frequencies and interactions
of the four major Type I diabetes-associated autoantibodies studied
in 9419 schoolchildren.
Diabetologia.
1999;
42
661-670
-
20
The Eurodiab Substudy 2 Study
Group .
Vitamin D supplement in early childhood and
risk for Type I (insulin-dependent) diabetes mellitus.
Diabetologia.
1999;
42
51-54
-
21
Verge C F, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase H P, Eisenbarth G S.
Number
of autoantibodies (against insulin, GAD or ICA512/IA2)
rather than particular autoantibody specificities determines risk
of type I diabetes.
J Autoimmun.
1996;
9
379-383
-
22
Verge C F, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson R A, Chase H P, Eisenbarth G S.
Prediction
of type I diabetes in first-degree relatives using a combination
of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
Diabetes.
1996;
45
926-933
-
23
Wahren J, Johansson B L.
Ernst-Friedrich-Pfeiffer
Memorial Lecture. New aspects of C-peptide physiology.
Horm
Metab Res.
1998;
30
A2-5
-
24
Ziegler A G, Hummel M, Schenker M, Bonifacio E.
Autoantibody Appearance
and Risk for the Development of Childhood Diabetes in Offspring of
Parents with Type 1 Diabetes: The German BABY-DIAB Study.
Diabetes.
1999;
48
460-468
Korrespondenz
Prof. Dr. med. Anette-G. Ziegler
Institut für Diabetesforschung und 3.
Med. Abteilung, Krankenhaus München-Schwabing
Kölner Platz 1
80804 München
Phone: 089/30793114
Fax: 089/3081733
Email: prevent.diabetes@lrz.uni-muenchen.de
